4th Annual RNA-Targeted Drug Discovery Summit - Digital Event - EST

Kongressthemen
As the first small-molecule drug targeting RNA gains momentum, the ability to design small molecules capable of interacting with and modulating RNA is opening as a new avenue to target challenging disease pathways that have previously been considered undruggable.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/851095-3?pid=4832

Speakers: Hashim Al-Hashimi, Professor, Duke University, Matthew Disney, Professor, Scripps Research, Jennifer Petter, Founder and Chief Innovation Officer, Arrakis Therapeutics and more

https://go.evvnt.com/851095-2?pid=4832

Frau Katie Jacobs